SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-009677
Filing Date
2019-05-13
Accepted
2019-05-13 16:50:11
Documents
65
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20190331_10q.htm 10-Q 499908
2 EXHIBIT 31.1 ex_143687.htm EX-31.1 12464
3 EXHIBIT 31.2 ex_143688.htm EX-31.2 12288
4 EXHIBIT 32.1 ex_143689.htm EX-32.1 4797
5 EXHIBIT 32.2 ex_143690.htm EX-32.2 5170
12 image01.jpg GRAPHIC 38803
  Complete submission text file 0001437749-19-009677.txt   3202262

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dmac-20190331.xml EX-101.INS 555448
7 XBRL TAXONOMY EXTENSION SCHEMA dmac-20190331.xsd EX-101.SCH 47250
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20190331_cal.xml EX-101.CAL 32545
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20190331_def.xml EX-101.DEF 260635
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20190331_lab.xml EX-101.LAB 232766
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20190331_pre.xml EX-101.PRE 286402
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 19819051
SIC: 2834 Pharmaceutical Preparations